Published in Neuroscience on December 01, 1995
Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell (2012) 2.62
The developmental integration of cortical interneurons into a functional network. Curr Top Dev Biol (2009) 2.01
Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences. Nat Neurosci (2013) 1.74
Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell (2010) 1.35
Distinct temporal requirements for the homeobox gene Gsx2 in specifying striatal and olfactory bulb neuronal fates. Neuron (2009) 1.28
Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat Protoc (2013) 1.25
LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons. Development (2009) 1.22
Interneurons from embryonic development to cell-based therapy. Science (2014) 1.21
Permissive corridor and diffusible gradients direct medial ganglionic eminence cell migration to the neocortex. Proc Natl Acad Sci U S A (2003) 1.08
TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proc Natl Acad Sci U S A (2011) 1.07
Retinoic acid functions as a key GABAergic differentiation signal in the basal ganglia. PLoS Biol (2011) 1.06
Ascl1 is a required downstream effector of Gsx gene function in the embryonic mouse telencephalon. Neural Dev (2009) 1.03
Cell therapy in Huntington's disease. NeuroRx (2004) 0.94
BDNF signaling and survival of striatal neurons. Front Cell Neurosci (2014) 0.90
The LIM homeobox gene Isl1 is required for the correct development of the striatonigral pathway in the mouse. Proc Natl Acad Sci U S A (2013) 0.89
Generation of striatal projection neurons extends into the neonatal period in the rat brain. J Physiol (2012) 0.85
Differentiation of pluripotent stem cells into striatal projection neurons: a pure MSN fate may not be sufficient. Front Cell Neurosci (2014) 0.83
Extended Production of Cortical Interneurons into the Third Trimester of Human Gestation. Cereb Cortex (2015) 0.83
Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges. Neurotherapeutics (2011) 0.81
The Zinc Finger Transcription Factor Sp9 Is Required for the Development of Striatopallidal Projection Neurons. Cell Rep (2016) 0.77
FoxP1 marks medium spiny neurons from precursors to maturity and is required for their differentiation. Exp Neurol (2016) 0.76
GABAA receptor activity shapes the formation of inhibitory synapses between developing medium spiny neurons. Front Cell Neurosci (2015) 0.75
Can manipulation of differentiation conditions eliminate proliferative cells from a population of ES cell-derived forebrain cells? Neurogenesis (Austin) (2016) 0.75
HSPC280, a winged helix protein expressed in the subventricular zone of the developing ganglionic eminences, inhibits neuronal differentiation. Histochem Cell Biol (2015) 0.75
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62
VITAMIN C TREATMENT IN LEAD POISONING. Science (1939) 3.92
Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol (1989) 3.24
Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci (1999) 3.06
A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol (2001) 2.98
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology (2000) 2.76
Subcellular localization of the human immunodeficiency virus trans-acting art gene product. J Virol (1988) 2.64
Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes. J Virol (1986) 2.50
Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature (1987) 2.33
Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol (1998) 2.20
Learning deficit in BDNF mutant mice. Eur J Neurosci (1997) 2.20
Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology (1998) 2.17
Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci (1999) 2.15
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci (1998) 2.10
Genetic control of dorsal-ventral identity in the telencephalon: opposing roles for Pax6 and Gsh2. Development (2000) 2.09
Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature (1999) 2.07
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Errors and violations on the roads: a real distinction? Ergonomics (2010) 1.96
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci (1995) 1.90
Nud1p links astral microtubule organization and the control of exit from mitosis. EMBO J (2000) 1.89
Specification of the anterior hindbrain and establishment of a normal mid/hindbrain organizer is dependent on Gbx2 gene function. Development (1997) 1.79
Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A (1986) 1.77
The role of compositionality in standardized problem list generation. Stud Health Technol Inform (1998) 1.69
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res (1979) 1.68
Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med (1993) 1.63
Spatial learning and motor deficits in aged rats. Neurobiol Aging (1984) 1.60
The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl (1974) 1.56
High-pressure suction drainage via a polyurethane foam in the management of poststernotomy mediastinitis. Ann Thorac Surg (2000) 1.54
Mesencephalic dopamine neurons projecting to neocortex. Brain Res (1974) 1.54
Umbilical cord prolapse. A contemporary look. J Reprod Med (1990) 1.52
The mouse IgH 3'-enhancer. Eur J Immunol (1991) 1.50
Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol (1994) 1.50
Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol (2001) 1.49
A role for Gsh1 in the developing striatum and olfactory bulb of Gsh2 mutant mice. Development (2001) 1.49
Personality traits are linked to crime among men and women: evidence from a birth cohort. J Abnorm Psychol (1994) 1.45
Topographic principles in the spinal projections of serotonergic and non-serotonergic brainstem neurons in the rat. Neuroscience (1985) 1.44
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons. Neurobiol Dis (2011) 1.43
Central conduction abnormalities after electrical injury. Muscle Nerve (1994) 1.42
DNA microsatellite analysis of Dolly. Nature (1998) 1.42
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res (1975) 1.39
The glyoxylic acid fluorescence histochemical method: a detailed account of the methodology for the visualization of central catecholamine neurons. Histochemistry (1974) 1.38
A role for Gbx2 in repression of Otx2 and positioning the mid/hindbrain organizer. Nature (1999) 1.37
Cell therapy in Parkinson's disease - stop or go? Nat Rev Neurosci (2001) 1.34
Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol (1983) 1.34
Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development (1999) 1.33
Development of the mesencephalic dopaminergic neuron system is compromised in the absence of neurogenin 2. Development (2006) 1.33
Lay definitions of ideal weight and overweight. Int J Obes Relat Metab Disord (1999) 1.31
An international outbreak of salmonellosis associated with raw almonds contaminated with a rare phage type of Salmonella enteritidis. J Food Prot (2005) 1.31
Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol (2000) 1.30
5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J Neurochem (1975) 1.29
Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol (1997) 1.29
Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma (2002) 1.28
The production of catecholamine-containing cells in vitro by young chick embryos: effects of "nerve growth factor" (NGF) and its antiserum. Neurobiology (1973) 1.28
Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A (1995) 1.26
Specification of mouse telencephalic and mid-hindbrain progenitors following heterotopic ultrasound-guided embryonic transplantation. Neuron (1997) 1.25
The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res (1973) 1.25
Mitochondrial function and redox state in mammalian embryos. Semin Cell Dev Biol (2009) 1.25
Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature (1990) 1.24
Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease. Brain (2000) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res (1988) 1.23
Soft drink consumption and excess weight gain in Australian school students: results from the Nepean study. Int J Obes (Lond) (2006) 1.22
Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res (1980) 1.21
Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand Suppl (1973) 1.21
Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res (1978) 1.21
Circadian rhythms in maternal plasma cortisol and estriol concentrations at 30 to 31, 34 to 35, and 38 to 39 weeks' gestational age. Am J Obstet Gynecol (1980) 1.20
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Dopamine-containing cells in sympathetic ganglia. Acta Physiol Scand (1970) 1.18
Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol Aging (1992) 1.17
Employment outcomes among AFDC recipients treated for substance abuse in Washington State. Milbank Q (2000) 1.17
Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene (1998) 1.16
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle. Eur J Neurosci (1999) 1.16
Guidelines on the management of acute myeloid leukaemia in adults. Br J Haematol (2006) 1.15
Regional incorporation and site-specific differentiation of striatal precursors transplanted to the embryonic forebrain ventricle. Neuron (1995) 1.15
A method for differentiating dopamine from noradrenaline in tissue sections by microspectrofluorometry. J Histochem Cytochem (1968) 1.15
Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain (1999) 1.14
Survival and functional outcome after prolonged intensive care unit stay. Ann Surg (2000) 1.13
Nerve growth factor: stimulation of regenerative growth of central noradrenergic neurons. Science (1972) 1.12
Preparing the wound bed--debridement, bacterial balance, and moisture balance. Ostomy Wound Manage (2000) 1.12
Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci (1997) 1.11
Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res (1986) 1.11
Maternal sensitivity and the security of infant-mother attachment: a Q-sort study. Child Dev (1990) 1.10
Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J Neurosci (1984) 1.10
Growth of central catecholamine neurones into smooth muscle grafts in the rat mesencephalon. Brain Res (1971) 1.09
Expression of Meis and Pbx genes and their protein products in the developing telencephalon: implications for regional differentiation. Mech Dev (2000) 1.09
The 3' region of bovine leukemia virus genome encodes a trans-activator protein. EMBO J (1986) 1.08
NGF improves spatial memory in aged rodents as a function of age. J Neurosci (1991) 1.06
Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci (1996) 1.06
Septal transplants restore maze learning in rats with fornix-fimbria lesions. Brain Res (1982) 1.06
Regulation of striatal serotonin release by the lateral habenula-dorsal raphe pathway in the rat as demonstrated by in vivo microdialysis: role of excitatory amino acids and GABA. Brain Res (1989) 1.05
Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience (1979) 1.05
Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine. Acta Physiol Scand Suppl (1971) 1.05
Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence. Neuroscience (1998) 1.05
Signaling-defective mutants of the B lymphocyte antigen receptor fail to associate with Ig-alpha and Ig-beta/gamma. J Biol Chem (1993) 1.04
Origin, course and termination of the mesohabenular dopamine pathway in the rat. Brain Res (1984) 1.04
Nonoperative management of unilateral neonatal hydronephrosis. J Urol (1992) 1.04
Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp Brain Res (1988) 1.04